Low-Cost, Handheld Light Sheet Microscope for Guiding Anal Cancer Diagnosis
用于指导肛门癌诊断的低成本手持式光片显微镜
基本信息
- 批准号:10382361
- 负责人:
- 金额:$ 17.51万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-04-15 至 2023-12-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdoptionAlgorithmic AnalysisAnusArchitectureBenignBiological MarkersBiopsyCellular MorphologyCervicalCervical Cancer ScreeningClinicalClinical ResearchComplicationConfocal MicroscopyCore BiopsyCytologyCytoplasmDetectionDevicesDiagnosisDiagnosticEarly DiagnosisEpithelialGoalsGoldHIV SeropositivityHistologyHomosexualsImageIncidenceLamina PropriaLateralLesionLightLightingMalignant - descriptorMalignant NeoplasmsMalignant neoplasm of anusMalignant neoplasm of cervix uteriMicroscopeMicroscopyMorbidity - disease rateMucous MembraneNeedlesNuclearOperative Surgical ProceduresOptical Coherence TomographyOpticsOralPainPap smearPerformanceProceduresProgram AppropriatenessResolutionScanningScreening procedureSensitivity and SpecificitySeveritiesSignal TransductionSkinSkin CancerSourceSpecificityStandardizationSurgical marginsTechnologyThickTimeTissuesVisualizationaccurate diagnosisautomated image analysisbasecancer diagnosiscancer preventioncellular imagingclinical applicationcostdesigndiagnostic accuracydiagnostic criteriafeasibility testingfluorescence imaginghistological imagehuman imagingimaging capabilitiesimaging probeimprovedin vivomenmicroscopic imagingmortalityprototypequality assurancescreening programtooltumor
项目摘要
Project Summary/Abstract
Anal cancer incidence has been increasing, by four times over the last three decades. The incidence rate is
unacceptably high among HIV-positive homosexual men, 131 per 100,000. The main challenge in anal cancer
diagnosis and prevention is the lack of a standardized screening program. In vivo optical microscopy
technologies such as confocal microscopy and optical coherence tomography have the potential to visualize
cellular morphologic changes associated with the anal malignancy, but their clinical adaptation has been
challenging. In this Trailblazer R21 project, we propose to develop a low-cost, scattering-based light sheet
microscopy (sLSM) device that can aid accurate diagnosis of anal cancer, with the goal of ultimately reducing
the anal cancer-associated morbidity and mortality. Our sLSM device will uniquely address the unmet needs in
existing in vivo microscopy technologies (e.g., CM, OCT), simultaneously achieving i) high lateral resolution (1-
2 µm) for examining cellular nuclear features in the epithelium, ii) large FOV (~2.5 mm), iii) visualization of the
entire epithelial thickness in a single image, and iv) low device cost (~$2,000). We expect that the sLSM device
will reveal the key diagnostic cellular features in vivo, which will facilitate detection of early-stage anal
malignancy and timely initiation of adequate treatment. The sLSM device will also guide the biopsy to
malignant lesions with high sensitivity and specificity to increase the biopsy yield and reduce the morbidity and
complication caused by the unnecessary biopsy of benign lesions. As the first step towards this goal, we will
develop the prototype handheld sLSM device and evaluate the accuracy of diagnosing anal malignancy in the
following aims: In Aim 1, we will develop a handheld sLSM probe for imaging anal mucosa. The sLSM device
will provide cellular resolution in the epithelium and reveal architectural details in deeper regions in a single
image. We will optimally design the illumination and detection optics to achieve the 1.4 µm lateral resolution
over a 2.5-mm FOV, 6.5 ± 0.9 µm axial resolution for the epithelium, and 18 ± 8 µm axial resolution for the
superficial lamina propria. In Aim 2, we will conduct a clinical study of imaging human anal tissues with the
handheld sLSM device. One hundred anal biopsies concerning for anal cancer will be first imaged with the
sLSM device. sLSM images will be compared with the corresponding histologic images to identify cellular and
architectural features visualized in sLSM images and to develop the sLSM diagnostic criteria. The sensitivity
and specificity of the sLSM for diagnosing anal malignancy will be evaluated. Automated image analysis
algorithms will be developed to quantitatively evaluate the cellular and architectural features. In addition to
providing a low-cost microscopy tool that aids accurate diagnosis of anal malignancy, the sLSM technology
can be used for in vivo diagnosis of other cancers (e.g., cervical, oral, skin cancers), intra-operative
assessment of the surgical margin, and quality assurance during the core needle biopsy.
项目摘要/摘要
肛门癌的发病率一直在上升,在过去的三十年里增加了四倍。发病率为
艾滋病毒阳性男同性恋者的比例高得令人无法接受,每10万人中有131人。肛门癌的主要挑战
诊断和预防缺乏标准化的筛查程序。活体光学显微镜
共聚焦显微镜和光学相干层析成像等技术具有可视化的潜力
与肛门恶性肿瘤相关的细胞形态变化,但它们的临床适应性已被
很有挑战性。在这个开拓者R21项目中,我们建议开发一种低成本的、基于散射的光片
显微镜(SLSM)设备,可以帮助准确诊断肛门癌,目标是最终减少
与肛门癌相关的发病率和死亡率。我们的sLSM设备将独一无二地满足
现有的活体显微镜技术(例如CM、OCT),同时实现了i)高横向分辨率(1-
2微米)用于检查上皮细胞的核特征,ii)大视野(~2.5 mm),iii)可视化
单个图像中的全部上皮厚度,以及iv)低设备成本(约2,000美元)。我们预计sLSM设备
将揭示体内关键的诊断细胞特征,这将有助于早期肛门的检测
恶性程度高,及时启动适当治疗。SLSM设备还将引导活检
恶性病变具有较高的敏感性和特异性,可提高活检产量,降低发病率和死亡率
良性病变不必要的活检引起的并发症。作为迈向这一目标的第一步,我们将
研制手持式sLSM样机并评价其对肛门恶性肿瘤诊断的准确性。
目标1:研制用于肛门黏膜成像的手持式sLSM探头。SLSM设备
将在上皮细胞中提供细胞分辨率,并在单个
图像。我们将对照明和探测光学进行优化设计,以实现1.4微米的横向分辨率
超过2.5 mm视野,上皮轴向分辨率为6.5±0.9微米,轴向分辨率为18±8微米
固有层浅层。在目标2中,我们将进行一项对人类肛门组织进行成像的临床研究
手持sLSM设备。100例与肛门癌有关的肛门活组织检查将首先使用
SLSM设备。SLSM图像将与相应的组织学图像进行比较,以识别细胞和
在sLSM图像中可视化的架构特征,并制定sLSM诊断标准。敏感度
并评价sLSM诊断肛门恶性肿瘤的特异性。自动图像分析
将开发算法来定量评估蜂窝和建筑特征。除了……之外
提供一种低成本的显微镜工具,帮助准确诊断肛门恶性肿瘤,sLSM技术
可用于其他癌症(如宫颈癌、口腔癌、皮肤癌)的活体诊断、术中
核心针活检时手术切缘的评估和质量保证。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dongkyun Kang其他文献
Dongkyun Kang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dongkyun Kang', 18)}}的其他基金
Portable In vivo Confocal Ophthalmoscope (PICO) for Accurate and Rapid Diagnosis of Corneal Ulcer
便携式体内共焦检眼镜 (PICO) 可准确快速诊断角膜溃疡
- 批准号:
10543508 - 财政年份:2022
- 资助金额:
$ 17.51万 - 项目类别:
High-speed, portable reflectance confocal microscope (pRCM) for imaging skin cancer
用于皮肤癌成像的高速便携式反射共焦显微镜 (pRCM)
- 批准号:
10381884 - 财政年份:2022
- 资助金额:
$ 17.51万 - 项目类别:
Portable In vivo Confocal Ophthalmoscope (PICO) for Accurate and Rapid Diagnosis of Corneal Ulcer
便携式体内共焦检眼镜 (PICO) 可准确快速诊断角膜溃疡
- 批准号:
10339950 - 财政年份:2022
- 资助金额:
$ 17.51万 - 项目类别:
Low-Cost, Handheld Light Sheet Microscope for Guiding Anal Cancer Diagnosis
用于指导肛门癌诊断的低成本手持式光片显微镜
- 批准号:
10212560 - 财政年份:2021
- 资助金额:
$ 17.51万 - 项目类别:
Low-Cost, Handheld Light Sheet Microscope for Guiding Anal Cancer Diagnosis
用于指导肛门癌诊断的低成本手持式光片显微镜
- 批准号:
10532759 - 财政年份:2021
- 资助金额:
$ 17.51万 - 项目类别:
Smartphone Confocal Endoscopy for Detecting Cervical Precancer
用于检测宫颈癌前病变的智能手机共焦内窥镜检查
- 批准号:
9554683 - 财政年份:2018
- 资助金额:
$ 17.51万 - 项目类别:
Smartphone confocal microscopy for diagnosing Kaposi’s sarcoma
用于诊断卡波西肉瘤的智能手机共焦显微镜
- 批准号:
9639153 - 财政年份:2015
- 资助金额:
$ 17.51万 - 项目类别:
相似海外基金
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
- 批准号:
10093543 - 财政年份:2024
- 资助金额:
$ 17.51万 - 项目类别:
Collaborative R&D
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
- 批准号:
24K16436 - 财政年份:2024
- 资助金额:
$ 17.51万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 17.51万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 17.51万 - 项目类别:
EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
- 批准号:
24K20973 - 财政年份:2024
- 资助金额:
$ 17.51万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 17.51万 - 项目类别:
EU-Funded
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
- 批准号:
10075502 - 财政年份:2023
- 资助金额:
$ 17.51万 - 项目类别:
Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
- 批准号:
10089082 - 财政年份:2023
- 资助金额:
$ 17.51万 - 项目类别:
EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
- 批准号:
481560 - 财政年份:2023
- 资助金额:
$ 17.51万 - 项目类别:
Operating Grants
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
- 批准号:
2321091 - 财政年份:2023
- 资助金额:
$ 17.51万 - 项目类别:
Standard Grant